Shares of Orchid Chemicals & Pharmaceuticals jumped 4 percent intraday Tuesday on its fund raising plans to ease out debts. As part of its corporate debt restructuring (CDR) scheme, the company has allotted 1.48 crore shares at Rs 49.79 per share on ... Moneycontrol.com, 2 days ago
Orchid Chemicals gains after allotment of shares to promoter group firm - Capital Market, 2 days ago
Orchid Pharma allots Rs 73 crore shares to promoter group firm - Business Standard, 2 days ago
1 images for "orchid chemicals and pharmaceuticals"
This page uses frames, but your browser doesn'tCapital Market, 2 days ago Orchid Chemicals & Pharma to hold committee meeting HDFC Securities, 1 week ago
CHENNAI: In a relief to beleaguered Orchid Chemicals and Pharmaceuticals Ltd, Madras High Court has set aside ING Vysya Bank declaring the pharma major as a willful defaulter and publish photographs of company's CMD K Raghavendra Rao and that of the ...New Indian Express, 1 month ago Orchid Pharma eyes full-capacity utilisation Business Standard India, 1 month ago Orchid Chemicals & Pharmaceuticals reports standalone net profit of Rs 271.94 crore in the September 2014 quarter Business Standard, 1 month ago Orchid Chemicals may head above Rs 80: Pritesh Mehta Money Control, 1 month ago
The fund infusion through preferential allotment is part of CDR package BS Reporter | Chennai November 26, 2014 Last Updated at 20:30 IST Orchid Healthcare Pvt Ltd, a promoter group firm of Orchid Chemicals and Pharmaceuticals Ltd, would pick up stakes to ...Business Standard, 4 weeks ago Promoter group to infuse Rs. 92 crore in Orchid Healthcare; stock 2% up India Infoline, 4 weeks ago
Orchid Chemicals and Pharmaceuticals has reported a net profit for the quarter ended September 30 due to extraordinary gain from transfer of the Penicillin and Penem API business. After adjusting for the extraordinary gain of ₹319 crore from ...Hindu Business Line, 1 month ago Orchid Chemicals & Pharmaceuticals : Gains from business transfer put Orchid Chem in the black in Q2 4 Traders, 1 month ago
The Court says that the decision is taken keeping the larger public interest in mind, as 25 other banks are involved BS Reporter | Chennai November 17, 2014 Last Updated at 20:20 IST The Madras High Court has issued an order in favour of a petition filed by ...Business Standard, 1 month ago
Cyrus Poonawalla, the billionaire horse breeder and chairman of Serum Institute, one of the world's largest vaccine makers, has said he would entertain an offer for his 14.5% stake in Orchid Chemicals at the right price. There's buzz in the market ...Times of India, 1 month ago CYRUS POONAWALLA : Poonawalla awaits right price for stake in Orchid Chemicals 4 Traders, 1 month ago
Top News US court not granted Ranbaxy appeal to block ANDA nod Ranbaxy Laboratories Ltd said that the Court has not granted Temporary Restraining Order to block FDA approval for other ANDAs for generic version of Nexium and Valganciclovir.India Infoline, 3 weeks ago
Despite reduction in prices of several medicines by NPPA, quality problems with US FDA, competition and slowdown in approvals, 50 top Indian pharmaceutical companies registered satisfactory growth in net sales and earnings before depreciation, ...PharmaBiz, 1 month ago
rkets today - Benchmark indices reversed gains to end lower after rising for three straight sessions amid a volatile day in which traders remained cautious ahead of the expiry of monthly equity derivatives contracts due tomorrow. Profit-booking in ...Stock Markets Review, 1 day ago
on your WebpageAdd Widget >Get your members hooked!